165 related articles for article (PubMed ID: 27727455)
1. Approaches, Challenges, and Advances in Metabolism of New Synthetic Cannabinoids and Identification of Optimal Urinary Marker Metabolites.
Diao X; Huestis MA
Clin Pharmacol Ther; 2017 Feb; 101(2):239-253. PubMed ID: 27727455
[TBL] [Abstract][Full Text] [Related]
2. Synthetic cannabinoids pharmacokinetics and detection methods in biological matrices.
Castaneto MS; Wohlfarth A; Desrosiers NA; Hartman RL; Gorelick DA; Huestis MA
Drug Metab Rev; 2015 May; 47(2):124-74. PubMed ID: 25853390
[TBL] [Abstract][Full Text] [Related]
3. Metabolism and toxicological analysis of synthetic cannabinoids in biological fluids and tissues.
Presley BC; Gurney SM; Scott KS; Kacinko SL; Logan BK
Forensic Sci Rev; 2016 Jul; 28(2):103-69. PubMed ID: 27257717
[TBL] [Abstract][Full Text] [Related]
4. Identification of AB-FUBINACA metabolites in authentic urine samples suitable as urinary markers of drug intake using liquid chromatography quadrupole tandem time of flight mass spectrometry.
Vikingsson S; Gréen H; Brinkhagen L; Mukhtar S; Josefsson M
Drug Test Anal; 2016 Sep; 8(9):950-6. PubMed ID: 26560240
[TBL] [Abstract][Full Text] [Related]
5. In silico and in vitro metabolism studies support identification of designer drugs in human urine by liquid chromatography/quadrupole-time-of-flight mass spectrometry.
Tyrkkö E; Pelander A; Ketola RA; Ojanperä I
Anal Bioanal Chem; 2013 Aug; 405(21):6697-709. PubMed ID: 23797910
[TBL] [Abstract][Full Text] [Related]
6. Identification of AKB-48 and 5F-AKB-48 Metabolites in Authentic Human Urine Samples Using Human Liver Microsomes and Time of Flight Mass Spectrometry.
Vikingsson S; Josefsson M; Gréen H
J Anal Toxicol; 2015; 39(6):426-35. PubMed ID: 25957385
[TBL] [Abstract][Full Text] [Related]
7. Detection of synthetic cannabinoids in oral fluid using ELISA and LC-MS-MS.
Rodrigues WC; Catbagan P; Rana S; Wang G; Moore C
J Anal Toxicol; 2013 Oct; 37(8):526-33. PubMed ID: 23946452
[TBL] [Abstract][Full Text] [Related]
8. Performance characteristics of an ELISA screening assay for urinary synthetic cannabinoids.
Spinelli E; Barnes AJ; Young S; Castaneto MS; Martin TM; Klette KL; Huestis MA
Drug Test Anal; 2015 Jun; 7(6):467-74. PubMed ID: 25167963
[TBL] [Abstract][Full Text] [Related]
9. Urinary prevalence, metabolite detection rates, temporal patterns and evaluation of suitable LC-MS/MS targets to document synthetic cannabinoid intake in US military urine specimens.
Wohlfarth A; Scheidweiler KB; Castaneto M; Gandhi AS; Desrosiers NA; Klette KL; Martin TM; Huestis MA
Clin Chem Lab Med; 2015 Feb; 53(3):423-34. PubMed ID: 25263309
[TBL] [Abstract][Full Text] [Related]
10. A rapid quantitative method for the analysis of synthetic cannabinoids by liquid chromatography-tandem mass spectrometry.
Freijo TD; Harris SE; Kala SV
J Anal Toxicol; 2014 Oct; 38(8):466-78. PubMed ID: 25217534
[TBL] [Abstract][Full Text] [Related]
11. "Smoking" guns: Questions. “Smoking” guns: Answers.
Cooks T; Davis TK; Hu J; Metheny R; Schwartz M; Gerona R
Pediatr Nephrol; 2016 Jan; 31(1):61-2, 63-6. PubMed ID: 25330878
[No Abstract] [Full Text] [Related]
12. Screening of synthetic cannabinoids in preserved oral fluid by UPLC-MS/MS.
Oiestad EL; Johansen U; Christophersen AS; Karinen R
Bioanalysis; 2013 Sep; 5(18):2257-68. PubMed ID: 24053241
[TBL] [Abstract][Full Text] [Related]
13. Determination and identification of synthetic cannabinoids and their metabolites in different matrices by modern analytical techniques - a review.
Znaleziona J; Ginterová P; Petr J; Ondra P; Válka I; Ševčík J; Chrastina J; Maier V
Anal Chim Acta; 2015 May; 874():11-25. PubMed ID: 25910441
[TBL] [Abstract][Full Text] [Related]
14. Metabolism of JWH-015, JWH-098, JWH-251, and JWH-307 in silico and in vitro: a pilot study for the detection of unknown synthetic cannabinoids metabolites.
Strano-Rossi S; Anzillotti L; Dragoni S; Pellegrino RM; Goracci L; Pascali VL; Cruciani G
Anal Bioanal Chem; 2014 Jun; 406(15):3621-36. PubMed ID: 24804821
[TBL] [Abstract][Full Text] [Related]
15. Simultaneous determination of four designer drugs and their major metabolites by liquid chromatography-mass spectrometry.
Chen X
J Chromatogr B Analyt Technol Biomed Life Sci; 2015 Jun; 992():1-7. PubMed ID: 25939091
[TBL] [Abstract][Full Text] [Related]
16. LC-QTOF-MS as a superior strategy to immunoassay for the comprehensive analysis of synthetic cannabinoids in urine.
Kronstrand R; Brinkhagen L; Birath-Karlsson C; Roman M; Josefsson M
Anal Bioanal Chem; 2014 Jun; 406(15):3599-609. PubMed ID: 24424965
[TBL] [Abstract][Full Text] [Related]
17. Focus on cannabinoids and synthetic cannabinoids.
Le Boisselier R; Alexandre J; Lelong-Boulouard V; Debruyne D
Clin Pharmacol Ther; 2017 Feb; 101(2):220-229. PubMed ID: 27861784
[TBL] [Abstract][Full Text] [Related]
18. LC/ESI-MS/MS method for quantification of 28 synthetic cannabinoids in neat oral fluid and its application to preliminary studies on their detection windows.
Kneisel S; Speck M; Moosmann B; Corneillie TM; Butlin NG; Auwärter V
Anal Bioanal Chem; 2013 May; 405(14):4691-706. PubMed ID: 23535743
[TBL] [Abstract][Full Text] [Related]
19. High-resolution mass spectrometric determination of the synthetic cannabinoids MAM-2201, AM-2201, AM-2232, and their metabolites in postmortem plasma and urine by LC/Q-TOFMS.
Zaitsu K; Nakayama H; Yamanaka M; Hisatsune K; Taki K; Asano T; Kamata T; Katagai M; Hayashi Y; Kusano M; Tsuchihashi H; Ishii A
Int J Legal Med; 2015 Nov; 129(6):1233-45. PubMed ID: 26349566
[TBL] [Abstract][Full Text] [Related]
20. [Analysis of illegal herbal products: identification of synthetic cannabinoids].
Akuzawa H
Chudoku Kenkyu; 2013 Mar; 26(1):28-34. PubMed ID: 23600264
[No Abstract] [Full Text] [Related]
[Next] [New Search]
